Protocol Ledger

NCT04946734 · Phase III · ACTIVE NOT RECRUITING

Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine

Interventional Phase III clinical trial protocol NCT04946734 sponsored by Guangdong Provincial People's Hospital in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-08-12 Enrollment: 440 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04946734
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)440 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04946734
Protocol FieldVerified Registry Value
NCT IdentifierNCT04946734
Consolidated Lead SponsorGuangdong Provincial People's Hospital
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment440 participants (ESTIMATED)
Registered Start Date2021-08-12
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI